Trademark: iTind 2064221
Word
iTind
ID
2064221
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
13 November 2019
Registration Date
13 November 2019
Renewal Date
13 November 2029
Owner(s)
Service
Madderns Pty Ltd
Goods and Services:
Class 10:
Medical devices for the treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders; medical devices for prostate, bladder and/or kidney related treatments, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical apparatus for the non-surgical treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders, comprised of stents, probes, obturators, temporary or permanent artificial implants, and catheters; catheter-type medical device for the therapeutic treatment of benign prostatic hyperplasia (BPH) and other urological disease states; medical devices for prostate tissue ablation or destruction, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical devices for use in tissue ablation, and the treatment of prostate cancer, kidney or renal tumors, and benign prostatic hyperplasia (BPH); medical apparatus and instruments for treating urological conditions and diseases in humans, namely, a medical device that provides a port-like access to the kidneys, ureters, bladder, or urethra of patients to allow access and drainage of the urinary system; medical device, namely a stent, temporary or permanent artificial implants, for placement in the urethra or prostate intended for removing prostate tissue through the urethra; medical devices, namely, stents, probes, obturators, temporary or permanent artificial implants, and catheters used to dilate strictured areas of the urethra.
Medical devices for the treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders; medical devices for prostate, bladder and/or kidney related treatments, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical apparatus for the non-surgical treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders, comprised of stents, probes, obturators, temporary or permanent artificial implants, and catheters; catheter-type medical device for the therapeutic treatment of benign prostatic hyperplasia (BPH) and other urological disease states; medical devices for prostate tissue ablation or destruction, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical devices for use in tissue ablation, and the treatment of prostate cancer, kidney or renal tumors, and benign prostatic hyperplasia (BPH); medical apparatus and instruments for treating urological conditions and diseases in humans, namely, a medical device that provides a port-like access to the kidneys, ureters, bladder, or urethra of patients to allow access and drainage of the urinary system; medical device, namely a stent, temporary or permanent artificial implants, for placement in the urethra or prostate intended for removing prostate tissue through the urethra; medical devices, namely, stents, probes, obturators, temporary or permanent artificial implants, and catheters used to dilate strictured areas of the urethra.